Women who breastfeed their infants for 13 months or longer are less likely to develop rheumatoid arthritis, according to an article published online May 13 in the Annals of the Rheumatic Diseases.
Women who breastfeed their infants for 13 months or longer are less likely to develop rheumatoid arthritis, according to an article published online May 13 in the Annals of the Rheumatic Diseases.
Mitra Pikwer, of Malmo University Hospital in Malmo, Sweden, and colleagues investigated whether breastfeeding and oral contraceptives affected the future risk of rheumatoid arthritis in a community-based cohort of 18,326 Swedish women. Lifestyle factors obtained from self-administered questionnaires were compared in 136 women with rheumatoid arthritis and 544 age-matched controls.
Prolonged breastfeeding was associated with a reduced risk of rheumatoid arthritis, the investigators found. Compared to women who did not breastfeed, the odds ratio was 0.46 for women who breastfed for at least 13 months and 0.74 for women who breastfed for between 1 and 12 months. The protective effect of prolonged breast-feeding remained significant after controlling for smoking and educational level, the report indicates. Oral contraceptives did not impact risk, the researchers note.
"Possible explanations for the protective effect of breastfeeding include long-term immunomodulation, such as the development of progesterone receptors on lymphocytes, dysregulated hypothalamic-pituitary-adrenal access, and differences in cortisol concentrations," the authors write.
Pikwer M, Bergström U, Nilsson JA, et al. Breast-feeding, but not oral contraceptives, is associated with a reduced risk of rheumatoid arthritis. Ann Rheum Dis. Published Online First: 14 May 2008. doi:10.1136/ard.2007.084707.
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More
SART data indicates rise in IVF use in 2022
April 24th 2024Dive into the latest statistics from the Society for Assisted Reproductive Technology, revealing a 6% increase in in vitro fertilization cycles and a surge in egg freezing, amidst a landscape of rising fertility service demand and evolving clinical practices.
Read More